Effective Control of COVID-19 in South Korea: Cross-Sectional Study of Epidemiological Data

Author:

Jeong Gwang HunORCID,Lee Hyo JeongORCID,Lee JinheeORCID,Lee Jun YoungORCID,Lee Keum HwaORCID,Han Young JooORCID,Yoon SojungORCID,Ryu SeohyunORCID,Kim Da KyungORCID,Park Myung BaeORCID,Yang Jae WonORCID,Effenberger MariaORCID,Eisenhut MichaelORCID,Hong Sung HwiORCID,Kronbichler AndreasORCID,Ghayda Ramy AbouORCID,Shin Jae IlORCID

Abstract

Background South Korea is one of the few countries that has succeeded in flattening the curve of new COVID-19 cases and avoiding a second outbreak by implementing multiple strategies, ranging from an individual level to the population level. Objective We aim to discuss the unique strategies and epidemiological characteristics of COVID-19 in South Korea and present a summary of policies implemented by the Korean government during the COVID-19 pandemic. Methods We designed a cross-sectional study of epidemiological data published by the Korea Centers for Disease Control and Prevention on October 1, 2020. We analyzed detailed epidemiological information of COVID-19 cases, including the number of confirmed cases and resulting deaths. Results As of October 1, 2020, a total of 23,889 confirmed COVID-19 cases and 415 deaths were reported in South Korea. In this paper, we present data on the epidemiological characteristics and transmission of the disease and discuss how the South Korean government, health care providers, and society responded to the COVID-19 outbreak. Conclusions Understanding the epidemiological characteristics of COVID-19 in South Korea and the government’s successful efforts in managing the spread of the disease can provide important insights to other countries dealing with the ongoing pandemic.

Publisher

JMIR Publications Inc.

Subject

Health Informatics

Reference23 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China

2. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)World Health Organization20200130Geneva, Switzerlandhttps://tinyurl.com/yxns3jfx

3. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020World Health Organization202002112020-10-07https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

4. COVID-19 ExplorerWorld Health Organization2020-10-07https://worldhealthorg.shinyapps.io/covid/

5. WHO Coronavirus Disease (COVID-19) DashboardWorld Health Organization2020-10-07https://covid19.who.int/

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3